Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Advocates press committee to allow Medicare supplement parity for under-65 ALS and ESRD patients; insurers warn of premium shifts
Summary
House Bill 323 (HB 3 23) would permit people under 65 with ALS or end-stage renal disease to purchase Medigap supplements at the same premium rates as people 65 and older; supporters cite small overall pool and state Medicaid savings while insurers warn of premium increases for older beneficiaries
Representative Karen Matheak introduced House Bill 323 to the Senate Insurance and Labor Committee, asking the panel to consider parity in Medicare supplemental (Medigap) premiums for people under age 65 who qualify for Medicare because they have end-stage renal disease (ESRD) or amyotrophic lateral sclerosis (ALS).
Supporters said the change would expand affordable access to Medigap policies for a small group of patients now facing sharply higher premiums and consequent financial strain. Elizabeth Lively, Eastern Region Advocacy Director for Dialysis Patient Citizens, cited an independent actuarial report from Health Management Associates that analyzed 2019 Medicare claims and estimated roughly 3,800 ESRD patients could…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
